Tables index

From

Docking Analysis of 07 Anti-HCV Drugs with COVID-19 Main Protease PDB ID: 6LU7

Ajeet , Babita Aggarwal, Santosh Kumar Verma, Ajeet Singh

American Journal of Pharmacological Sciences. 2020, 8(2), 21-25 doi:10.12691/ajps-8-2-1
  • Table 1. Daclatasvir- Hydrophobic Interactions
  • Table 2. Daclatasvir- Hydrogen Bonds Interaction
  • Table 3. Dasabuvir - Hydrophobic Interactions
  • Table 4. Dasabuvir -Hydrogen Bonds Interaction
  • Table 5. Elbasvir -Hydrophobic Interactions
  • Table 6. Elbasvir -Hydrogen Bonds Interaction
  • Table 7. Ledipasvir -Hydrophobic Interactions
  • Table 8. Ledipasvir -Hydrogen Bonds Interactions
  • Table 9. Lomibuvir -Hydrophobic Interactions
  • Table 10. Lomibuvir- Hydrogen Bonds Interactions
  • Table 11. Ombitasvir- Hydrophobic Interactions
  • Table 12. Ombitasvir - Hydrogen Bonds Interactions
  • Table 13. Paritaprevir - Hydrophobic Interactions
  • Table 14. Paritaprevir - Hydrogen Bonds Interactions
  • Table 15. N3 Reference molecule- Hydrophobic Interactions
  • Table 16. N3 Reference molecule- Hydrogen Bond Interaction
  • Table 17. Residual analysis of docked anti-HCV drugs